Eisai
4523.T
#2148
Rank
NZ$15.92 B
Marketcap
NZ$56.42
Share price
-0.71%
Change (1 day)
8.93%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.54. In 2026 the company made an earnings per share (EPS) of NZ$1.53 a decrease over its 2025 EPS that were of NZ$1.94.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026NZ$1.53-21.04%
2025NZ$1.9411.85%
2024NZ$1.74-32.63%
2023NZ$2.585.52%
2022NZ$2.44-74.01%
2021NZ$9.40-66.58%
2020NZ$28.1198.24%
2019NZ$14.1817.01%
2018NZ$12.1237.78%
2017NZ$8.80-27.62%
2016NZ$12.1535.33%
2015NZ$8.98-2.82%
2014NZ$9.24-27.66%
2013NZ$12.78-27.49%
2012NZ$17.62-12.67%
2011NZ$20.1888.08%
2010NZ$10.73-11.06%
2009NZ$12.06-390.15%
2008NZ-$4.16-127.78%
2007NZ$14.97347.11%
2006NZ$3.354.38%
2005NZ$3.217.4%
2004NZ$2.9943.03%
2003NZ$2.0925.09%
2002NZ$1.6752.67%
2001NZ$1.0969.76%
2000NZ$0.64